Effect of dexmedetomidine on acute lung injury in experimental ischemia-reperfusion model
Efeito de dexmedetomidina sobre lesão pulmonar aguda em modelo experimental de isquemia-reperfusão
Ömer Burak Küçükebe; Deniz Özzeybek; Ruslan Abdullayev; Adil Ustaoğ; lu; Iş; ı; l Tekmen; Tuncay Küme
Abstract
Keywords
Resumo
Palavras-chave
References
Cerra FB, Lajos TZ, Montes M. Hemorrhagic infarction: a reperfusion injury following prolonged myocardial ischemic anoxia. Surgery. 1975;78:95-104.
Welbourn CR, Goldman G, Paterson IS. Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg. 1991;78:651-5.
Grace PA. Ischaemia-reperfusion injury. Br J Surg. 1994;81:637-47.
Vilcek J. The cytokines: an overview. The Cytokine Handbook. 2003;vol. 1:3-18.
Seekamp A, Mulligan MS, Till GO. Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury. Am J Pathol. 1993;143:453-63.
Seekamp A, Till GO, Mulligan MS. Role of selectins in local and remote tissue injury following ischemia and reperfusion. Am J Pathol. 1994;144:592-8.
Yassin MM, Barros D'Sa AA, Parks G. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J Surg. 2002;26:115-21.
Maes M, Lin A, Kenis G. The effects of noradrenaline and alpha-2 adrenoceptor agents on the production of monocytic products. Psychiatry Res. 2000;96:245-53.
Venn RM, Bryant A, Hall GM. Preliminary UK experience of dexmedetomidine a novel agent for postoperative sedation in the intensive care unit. Anaesthesia. 1999;54:1136-42.
Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs. 2000;59:263-70.
Taniguchi T, Kidani Y, Kanakura H. Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats. Crit Care Med. 2004;32:1322-6.
Jolkkonen J, Puurunen K, Koistinaho J. Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia. Eur J Pharmacol. 1999;372:31-6.
Eser O, Fidan H, Sahin O. The influence of dexmedetomidine on ischemic rat hippocampus. Brain Res. 2008;1218:250-6.
Yagmurdur H, Ozcan N, Dokumaci F. Dexmedetomidine reduces the ischemia-reperfusion injury markers during upper extremity surgery with tourniquet. J Hand Surg Am. 2008;33:941-7.
Yang CL, Tsai PS, Huang CJ. Effects of dexmedetomidine on regulating pulmonary inflammation in a rat model of ventilator-induced lung injury. Acta Anaesthesiol Taiwan. 2008;46:151-9.
Kocoglu H, Ozturk H, Ozturk H. Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: a histopathologic study. Ren Fail. 2009;31:70-4.
Tassiopoulos AP, Carlin RE, Gao Y. Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities. J Vasc Surg. 1997;26:647-56.
Duru S, Koca U, Öztekin S. Antithrombin III pretreatment reduces neutrophil recruitment into the lung and skeletal muscle tissues in the rat model of bilateral lower limb and reperfusion: a pilot study. Acta Anaesthesiol Scand. 2005;49:1142-8.
Khalil AA, Aziz FA, Hall JC. Reperfusion injury. Plast Reconstr Surg. 2006;117:1024-33.
Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg. 2002;10:620-30.
Petrasek PF, Homer-Vanniasinkam S, Walker PM. Determinants of ischemic injury to skeletal muscle. J Vasc Surg. 1994;19:623-31.
Seal JB, Gewertz BL. Vascular dysfunction in ischemia-reperfusion injury. Ann Vasc Surg. 2005;19:572-84.
Yao YM, Sheng ZY, Yu Y. The potential etiologic role of tumor necrosis factor in mediating multiple organ dysfunction in rats following intestinal ischemia-reperfusion injury. Resuscitation. 1995;29:157-68.
Roumen RM, Hendriks T, van der Ven-Jonge KJ. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg. 1993;218:769-76.
Koroglu A, Demirbilek S, Teksan H. Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth. 2005;94:821-4.
Arain SR, Ruehlow RM, Uhrich TD. The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg. 2004;98:153-8.
Shen J, Fu G, Jiang L. Effect of dexmedetomidine pretreatment on lung injury following intestinal ischemia-reperfusion. Exp Ther Med. 2013;6:1359-64.
Engelhard K, Werner C, Eberspacher E. The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg. 2003;96:524-31.
Welbourn R, Goldman G, O'Riordain M. Role for tumor necrosis factor as mediator of lung injury following lower torso ischemia. J Appl Physiol. 1991;70:2645-9.
Harkin DW, Barros D'Sa AA, McCallion K. Ischemic preconditioning before lower limb ischemia-reperfusion protects against acute lung injury. J Vasc Surg. 2002;35:1264-73.
Gaines GC, Welborn 3rd MB, Moldawer LL. Attenuation of skeletal muscle ischemia/reperfusion injury by inhibition of tumor necrosis factor. J Vasc Surg. 1999;29:370-6.